Literature DB >> 11735655

Treating epilepsy in the elderly: safety considerations.

S Arroyo1, G Kramer.   

Abstract

The incidence of epilepsy increases with advancing age. Epilepsy in the elderly has different aetiologies from that in younger populations, cerebrovascular disease being the most common condition associated with seizures. Partial seizures are the predominant seizure type in older patients. A diagnosis of epilepsy in the elderly is based mainly on the history and is frequently delayed. In addition, seizure imitators are especially frequent. In many cases ancillary tests for diagnosis may show normal age-related variants, sometimes making results difficult to interpret. Treating epilepsy in the elderly is problematic due to a number of issues that relate to age and comorbidity. The physical changes associated with increasing age frequently lead to changes in the pharmacokinetics of many anticonvulsants. The treatment of epilepsy in the elderly is also complicated by the existence of other diseases that might affect the metabolism or excretion of anticonvulsants and the presence of concomitant medications that might interact with them. Moreover, specific trials of anticonvulsants in the aged population are scarce. General guidelines for treatment include starting at lower doses, slowing the titration schedule, individualising the choice of anticonvulsant to the characteristics of the patient, avoiding anticonvulsants with important cognitive or sedative adverse effects, and where possible, treating with monotherapy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11735655     DOI: 10.2165/00002018-200124130-00006

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  216 in total

1.  Weight gain in epileptic patients during treatment with valproic acid: a retrospective study.

Authors:  C L Corman; N M Leung; A H Guberman
Journal:  Can J Neurol Sci       Date:  1997-08       Impact factor: 2.104

2.  Population pharmacokinetics of lamotrigine monotherapy in patients with epilepsy: retrospective analysis of routine monitoring data.

Authors:  Z Hussein; J Posner
Journal:  Br J Clin Pharmacol       Date:  1997-05       Impact factor: 4.335

3.  Diagnostic yield and development of a neurocardiovascular investigation unit for older adults in a district hospital.

Authors:  L M Allcock; D O'Shea
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2000-08       Impact factor: 6.053

4.  Idiopathic first seizure in adult life: who should be treated?

Authors:  C A van Donselaar; A T Geerts; R J Schimsheimer
Journal:  BMJ       Date:  1991-03-16

5.  Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome. Lamictal Lennox-Gastaut Study Group.

Authors:  J Motte; E Trevathan; J F Arvidsson; M N Barrera; E L Mullens; P Manasco
Journal:  N Engl J Med       Date:  1997-12-18       Impact factor: 91.245

6.  Absence of pharmacokinetic drug interaction of levetiracetam with phenytoin in patients with epilepsy determined by new technique.

Authors:  T R Browne; G K Szabo; I E Leppik; E Josephs; J Paz; E Baltes; C M Jensen
Journal:  J Clin Pharmacol       Date:  2000-06       Impact factor: 3.126

Review 7.  Pharmacology and pharmacokinetics of fosphenytoin.

Authors:  T R Browne; A R Kugler; M A Eldon
Journal:  Neurology       Date:  1996-06       Impact factor: 9.910

8.  Drug interactions of zonisamide with phenytoin and sodium valproate: serum concentrations and protein binding.

Authors:  K Tasaki; T Minami; I Ieiri; K Ohtsubo; Y Hirakawa; K Ueda; S Higuchi
Journal:  Brain Dev       Date:  1995 May-Jun       Impact factor: 1.961

9.  Incidence and clinical characterization of unprovoked seizures in adults: a prospective population-based study.

Authors:  L Forsgren; G Bucht; S Eriksson; L Bergmark
Journal:  Epilepsia       Date:  1996-03       Impact factor: 5.864

10.  Reversible parkinsonism and cognitive impairment with chronic valproate use.

Authors:  C Armon; C Shin; P Miller; S Carwile; E Brown; J D Edinger; R G Paul
Journal:  Neurology       Date:  1996-09       Impact factor: 9.910

View more
  9 in total

Review 1.  Epilepsy in elderly people.

Authors:  Martin J Brodie; Patrick Kwan
Journal:  BMJ       Date:  2005-12-03

Review 2.  Zonisamide: a review of its use in the management of partial seizures in epilepsy.

Authors:  James E Frampton; Lesley J Scott
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

3.  Pathophysiological considerations of seizures, epilepsy, and status epilepticus in the elderly.

Authors:  Rebecca M Verellen; Jose E Cavazos
Journal:  Aging Dis       Date:  2011-08-30       Impact factor: 6.745

Review 4.  Traditional and Novel Migraine Therapy in the Aging Population.

Authors:  Shema Mathew; Jessica Ailani
Journal:  Curr Pain Headache Rep       Date:  2019-05-11

5.  Selection of antiepileptic drugs in older people.

Authors:  Batool F Kirmani; Diana Mungall Robinson; Adeline Kikam; Ekokobe Fonkem; Daniel Cruz
Journal:  Curr Treat Options Neurol       Date:  2014-06       Impact factor: 3.972

Review 6.  Review of topiramate for the treatment of epilepsy in elderly patients.

Authors:  B R Sommer; H H Fenn
Journal:  Clin Interv Aging       Date:  2010-04-26       Impact factor: 4.458

Review 7.  Seizures in elderly patients with dementia: epidemiology and management.

Authors:  Mario Mendez; Gerald Lim
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

Review 8.  Selection criteria for the clinical use of the newer antiepileptic drugs.

Authors:  Charles L P Deckers; P D Knoester; G J de Haan; A Keyser; W O Renier; Y A Hekster
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

Review 9.  [Seizures and epilepsies after stroke].

Authors:  H M Hamer
Journal:  Nervenarzt       Date:  2009-04       Impact factor: 1.214

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.